article thumbnail

FTA awarding $130M in Low-No grants for zero-emission and low-emission transit buses and facilities

Green Car Congress

New Jersey Transit Corporation. The Southeastern Pennsylvania Transportation Authority (SEPTA) will receive funds for infrastructure upgrades to support its current battery electric bus fleet at a maintenance facility in Philadelphia, PA. New Mexico Department of Transportation. Rhode Island Public Transit Authority (RIPTA).

Emissions 186
article thumbnail

PECO Expanding Fleet with NGVs & PHEVs

Green Car Congress

The utility is participating in a national consortium that recently was awarded a federal stimulus grant to purchase plug-in hybrid electric vehicles (PHEVs), and the company is buying more trucks to run on compressed natural gas (CNG) as well. The NGVs will be used by PECO’s energy technicians in the Philadelphia suburbs.

PHEV 186
article thumbnail

New York City adding 70 electric vehicles to fleet; launches EV educational push

Green Car Congress

The City is also collaborating with the cities of Boston and Philadelphia as part of the Northeast Regional Electric Vehicle Partnership to improve conditions for electric vehicles and alleviate barriers to early electric vehicle adoption through low-cost, high-impact actions.

article thumbnail

Xerox Parc’s Engineers on How They Invented the Future—and How Xerox Lost It

Cars That Think

When the center opened in 1970, it was unlike other major industrial research laboratories; its work wasn’t tied, even loosely, to its corporate parent’s current product lines. Shoup stayed at PARC, supported by Kay’s research group, while Smith moved on, armed with a National Education Association grant to do computer art.

Future 145
article thumbnail

When New York City Was a Wiretapper’s Dream

Cars That Think

Subscribers whose phones were tapped at the time of the raid included a range of New York commercial interests, with assets both large and small: a modeling agency and an insurance company; an art gallery and a lead mining company; and perhaps most sensationally, two publicly traded pharmaceutical corporations with competing patent interests.